Ranbaxy Laboratories, which will soon become a part of Sun Pharma, will announce its third quarter (October-December) earnings today. Analysts expect the quarter to be a good one due to Diovan generic (is used to treat high blood pressure).
first published: Jan 28, 2015 11:15 am
A collection of the most-viewed Moneycontrol videos.
